Showing results (1-10 of 961) with videos related to

Sort By:
Pageof 97
Ejhaem|October 19, 2020
Pevonedistat, a NEDD8-Activating Enzyme Inhibitor, Induces Apoptosis and Augments Efficacy of Chemotherapy and Small Molecule Inhibitors in Pre-clinical Models of Diffuse Large B-cell LymphomaPallawi Torka, Cory Mavis, Shalin Kothari, et al.
Ejhaem|July 6, 2021
Acquired thrombotic thrombocytopenic purpura with possible association with AstraZeneca-Oxford COVID-19 vaccineMona Al-Ahmad, Mona Al-Rasheed, Neveen Abo Bakr Shalaby
Ejhaem|July 6, 2021
In-hospital mortality in SARS-CoV-2 stratified by hemoglobin levels: A retrospective studyMohammed Al-Jarallah, Rajesh Rajan, Ahmad Al Saber, et al.
Ejhaem|July 6, 2021
Models of care for chronic myeloid leukemia patients during the COVID-19 pandemic in the United Kingdom: Changes in patient attitudes to remote consultations and future implicationsNicholas Duncan, Nigel Deekes, David FitzGerald, et al.
Ejhaem|December 5, 2022
Understanding real-world treatment patterns and clinical outcomes in AL amyloidosis patients diagnosed in Canada: A population-based cohort studyVictor H Jimenez-Zepeda, Donna Reece, Rodrigo Rigo, et al.
Ejhaem|December 5, 2022
Selinexor-based regimens in patients with multiple myeloma after prior anti-B-cell maturation antigen treatmentMuhamed Baljevic, Cristina Gasparetto, Gary J Schiller, et al.
Ejhaem|December 5, 2022
Bortezomib-based therapy is effective and well tolerated in frontline and multiply pre-treated Waldenström macroglobulinaemia including BTKi failures: A real-world analysisJahanzaib Khwaja, Encarl Uppal, Robert Baker, et al.
Ejhaem|December 5, 2022
Carfilzomib usage patterns and outcomes in patients with relapsed multiple myeloma: A multi-institutional report from the Canadian Myeloma Research Group (CMRG) DatabaseArleigh McCurdy, Martha Louzada, Christopher P Venner, et al.
Ejhaem|December 5, 2022
Protein profiling by reverse phase protein array (RPPA) in classical hairy cell leukemia (HCL) and HCL-variantFieke W Hoff, Ti'ara L Griffen, Yihua Qiu, et al.
Ejhaem|December 5, 2022
A new aberrantly spliced BCR-ABL1 transcript variant (e13a1) identified in routine monitoring using different quantitative reverse transcription polymerase chain reaction techniques in a patient with chronic myeloid leukemiaNicole Naumann, Ulrike Bross-Bach, Wolfgang Seifarth, et al.
Pageof 97